ID: ALA1907935

Max Phase: Preclinical

Molecular Formula: C9H19NO

Molecular Weight: 157.26

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  N[C@@H](CO)CC1CCCCC1

Standard InChI:  InChI=1S/C9H19NO/c10-9(7-11)6-8-4-2-1-3-5-8/h8-9,11H,1-7,10H2/t9-/m1/s1

Standard InChI Key:  QWDRYURVUDZKSG-SECBINFHSA-N

Associated Targets(non-human)

Phenylethanolamine N-methyltransferase 752 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 157.26Molecular Weight (Monoisotopic): 157.1467AlogP: 1.28#Rotatable Bonds: 3
Polar Surface Area: 46.25Molecular Species: BASEHBA: 2HBD: 2
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 9.83CX LogP: 1.23CX LogD: -1.11
Aromatic Rings: 0Heavy Atoms: 11QED Weighted: 0.65Np Likeness Score: 0.89

References

1. Grunewald GL, Monn JA, Rafferty MF, Borchardt RT, Krass P..  (1982)  Probes of the active site of norepinephrine N-methyltransferase: effect of hydrophobic and hydrophilic interactions on side-chain binding of amphetamine and alpha-methylbenzylamine.,  25  (10): [PMID:7143366] [10.1021/jm00352a031]

Source